Grifols reported EUR1.95B in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alaunos Therapeutics USD 46M 39M Jun/2026
Arca Biopharma USD 1.47B 537M Dec/2025
Bio Path USD 1000K 0 Sep/2025
Brainstorm Cell Therapeutics USD 8M 3M Sep/2025
Capricor Therapeutics USD 1.66B 1.33B Dec/2025
Cara Therapeutics USD 366M 338M Sep/2025
Esperion Therapeutics USD 885M 351M Dec/2025
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
Immunic USD 64M 23M Dec/2025
Infinity Pharmaceuticals USD 0 0 Apr/2026
Nektar Therapeutics USD 11.91B 11.05B Jun/2026